Literature DB >> 34890067

Dickkopf proteins in pathological inflammatory diseases.

Min Hee Park1,2, Jae Hun Shin3, Alfred L M Bothwell3, Wook-Jin Chae1,2.   

Abstract

The human body encounters various challenges. Tissue repair and regeneration processes are augmented after tissue injury to reinstate tissue homeostasis. The Wnt pathway plays a crucial role in tissue repair since it induces target genes required for cell proliferation and differentiation. Since tissue injury causes inflammatory immune responses, it has become increasingly clear that the Wnt ligands can function as immunomodulators while critical for tissue homeostasis. The Wnt pathway and Wnt ligands have been studied extensively in cancer biology and developmental biology. While the Wnt ligands are being studied actively, how the Wnt antagonists and their regulatory mechanisms can modulate immune responses during chronic pathological inflammation remain elusive. This review summarizes DKK family proteins as immunomodulators, aiming to provide an overarching picture for tissue injury and repair. To this end, we first review the Wnt pathway components and DKK family proteins. Next, we will review DKK family proteins (DKK1, 2, and 3) as a new class of immunomodulatory protein in cancer and other chronic inflammatory diseases. Taken together, DKK family proteins and their immunomodulatory functions in chronic inflammatory disorders provide novel insights to understand immune diseases and make them attractive molecular targets for therapeutic intervention. ©2021 Society for Leukocyte Biology.

Entities:  

Keywords:  Wnt; antagonist; cancer; immunology

Mesh:

Substances:

Year:  2021        PMID: 34890067     DOI: 10.1002/JLB.3RI0721-385R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  1 in total

1.  Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience.

Authors:  Savino Sciascia; Alice Barinotti; Massimo Radin; Irene Cecchi; Elisa Menegatti; Edoardo Terzolo; Daniela Rossi; Simone Baldovino; Roberta Fenoglio; Dario Roccatello
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.